(January 12, 2024, 10:05 AM EST) -- SILVER SPRINGS, Md. — The U.S. Food and Drug Administration said it “is evaluating the need for regulatory action” after receiving reports that diabetes and diet drugs such as Ozempic, Wegovy and Mounjaro may cause alopecia, aspiration and suicidal ideation....